STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

KALV KALVISTA PHARMACEUTICALS INCORPORATED StockScouter® Report

2

StockScouter® Score

KALVISTA PHARMACEUTICALS INCORPORATED, a small cap growth company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are under accumulation by financial institutions. Marginally positive for a small company like KALV

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • The 50-day moving average for KALV is below its 200-day moving average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, growth stocks will be in favor, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 80% done.
Progress: 20% done.
Low
High

Core Model Grades

F
C
F
C

Previous Ratings

2
3
4